Form 4: Sangamo Therapeutics Executive Surrenders Shares for Tax Withholding
SEC Form 4 Filing
Scott B. Willoughby, SVP, General Counsel & Secretary of Sangamo Therapeutics, surrendered shares to cover tax obligations upon vesting of a restricted stock unit.
Summary
- On August 13, 2024, Scott B. Willoughby, SVP, General Counsel & Secretary of Sangamo Therapeutics, surrendered 892 shares of common stock to the issuer for tax withholding purposes.
- The shares were surrendered at a price of $0.9751 per share, the closing stock price on August 13, 2024.
- This transaction was related to the vesting of a portion of a Restricted Stock Unit (RSU) grant.
- Following the transaction, Willoughby directly owns 832,802 shares of Sangamo Therapeutics common stock.
- These holdings include shares from previous RSU grants that are vesting over time.
Sentiment
Score: 5
Explanation: This is a neutral filing related to standard executive compensation practices. It doesn't contain information that would significantly impact investor sentiment positively or negatively.
Future Outlook
The document outlines the vesting schedules of several RSU grants, indicating future equity compensation for the reporting person contingent on continued service.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates standard compensation practices through equity grants.
Key Dates
| Date | Description |
|---|---|
| 08/13/2021 | Date of a previous RSU grant to the Reporting Person. |
| 02/25/2022 | Date of a previous RSU grant to the Reporting Person. |
| 02/24/2023 | Date of a previous RSU grant to the Reporting Person. |
| 01/22/2024 | Date of a previous RSU grant to the Reporting Person. |
| 08/13/2024 | Date of the transaction where shares were surrendered for tax withholding; also the final vesting installment of the Reporting Person's August 13, 2021 RSU grant. |
| 08/15/2024 | Date of the Form 4 filing. |
| 02/25/2025 | Date through which shares subject to Reporting Person's February 25, 2022 RSU grant will vest in successive equal quarterly installments. |
| 02/24/2026 | Date through which shares subject to Reporting Person's February 24, 2023 RSU grant will vest in successive equal quarterly installments. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.